Hepatocyte-Specific Smad7 Expression Attenuates TGF-β-Mediated Fibrogenesis and Protects Against Liver Damage

Gastroenterology

Volumn 135, Issue 2, 2008, Pages

  Dooley, Steven ^a   Hamzavi, Jafar ^a   Ciuclan, Loredana ^a   Godoy, Patricio ^a   Ilkavets, Iryna ^a   Ehnert, Sabrina ^a   Ueberham, Elke ^b   Gebhardt, Rolf ^b   Kanzler, Stephan ^c   Geier, Andreas ^d   Breitkopf, Katja ^a   Weng, Honglei ^a   Mertens, Peter R ^e  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; COLLAGEN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL LINE; CELL SURVIVAL; CELL TYPE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; EPITHELIUM; FIBROGENESIS; IN VITRO STUDY; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 48549084059     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.04.038     Document Type: Article

References (50)

1. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117 (2007) 524-529
2. Hinz B., Phan S.H., Thannickal V.J., et al. The myofibroblast: one function, multiple origins. Am J Pathol 170 (2007) 1807-1816
3. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112 (2003) 1776-1784
4. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117 (2007) 539-548
5. Miyazawa K., Shinozaki M., Hara T., et al. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7 (2002) 1191-1204
6. Rubtsov Y.P., and Rudensky A.Y. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 7 (2007) 443-453
7. Gressner A.M., Weiskirchen R., Breitkopf K., et al. Roles of TGF-beta in hepatic fibrosis. Front Biosci 7 (2002) d793-d807
8. Annoni G., Weiner F.R., and Zern M.A. Increased transforming growth factor-beta 1 gene expression in human liver disease. J Hepatol 14 (1992) 259-264
9. Leask A., and Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J 18 (2004) 816-827
10. Breitkopf K., Godoy P., Ciuclan L., et al. TGF-beta/Smad signaling in the injured liver. Z Gastroenterol 44 (2006) 57-66
11. Nakao A., Fujii M., Matsumura R., et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104 (1999) 5-11
12. Dooley S., Hamzavi J., Breitkopf K., et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125 (2003) 178-191
13. Yamamura Y., Hua X., Bergelson S., et al. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis. J Biol Chem 275 (2000) 36295-36302
14. Klingmuller U., Bauer A., Bohl S., et al. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) 153 (2006) 433-447
15. Ju W., Ogawa A., Heyer J., et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 26 (2006) 654-667
16. Breitkopf K., Roeyen C., Sawitza I., et al. Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC). Cytokine 31 (2005) 349-357
17. Dennler S., Itoh S., Vivien D., et al. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17 (1998) 3091-3100
18. Stopa M., Anhuf D., Terstegen L., et al. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem 275 (2000) 29308-29317
19. Breitkopf K., Sawitza I., Westhoff J.H., et al. Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut 54 (2005) 673-681
20. Lindert S., Wickert L., Sawitza I., et al. Transdifferentiation-dependent expression of alpha-SMA in hepatic stellate cells does not involve TGF-beta pathways leading to coinduction of collagen type I and thrombospondin-2. Matrix Biol 24 (2005) 198-207
21. Dooley S., Delvoux B., Lahme B., et al. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31 (2000) 1094-1106
22. Gotzmann J., Huber H., Thallinger C., et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J Cell Sci 115 (2002) 1189-1202
23. Wiercinska E., Wickert L., Denecke B., et al. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43 (2006) 1032-1041
24. Tesseur I., Zou K., Berber E., et al. Highly sensitive and specific bioassay for measuring bioactive TGF-beta. BMC Cell Biol 7 (2006) 15
25. Kanzler S., Lohse A.W., Keil A., et al. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 276 (1999) G1059-G1068
26. Ueberham E., Low R., Ueberham U., et al. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37 (2003) 1067-1078
27. Li R., Rosendahl A., Brodin G., et al. Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol 176 (2006) 6777-6784
28. Jamall I.S., Finelli V.N., and Que Hee S.S. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 112 (1981) 70-75
29. Yoo J., Ghiassi M., Jirmanova L., et al. Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem 278 (2003) 43001-43007
30. Dooley S., Streckert M., Delvoux B., et al. Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun 283 (2001) 554-562
31. Valcourt U., Kowanetz M., Niimi H., et al. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16 (2005) 1987-2002
32. Itoh M., Furuse M., Morita K., et al. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147 (1999) 1351-1363
33. Yap A.S., Brieher W.M., and Gumbiner B.M. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 13 (1997) 119-146
34. Wodarz A., and Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14 (1998) 59-88
35. Ueberham E., Low R., Ueberham U., et al. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37 (2003) 1067-1078
36. Kanzler S., Lohse A.W., Keil A., et al. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 276 (1999) G1059-G1068
37. Russo F.P., Alison M.R., Bigger B.W., et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130 (2006) 1807-1821
38. Forbes S.J., Russo F.P., Rey V., et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126 (2004) 955-963
39. Kinnman N., and Housset C. Peribiliary myofibroblasts in biliary type liver fibrosis. Front Biosci 7 (2002) d496-d503
40. Li Z., Dranoff J.A., Chan E.P., et al. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 46 (2007) 1246-1256
41. Oberhammer F.A., Pavelka M., Sharma S., et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A 89 (1992) 5408-5412
42. Sanderson N., Factor V., Nagy P., et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92 (1995) 2572-2576
43. Weng H.L., Ciuclan L., Liu Y., et al. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 46 (2007) 1257-1270
44. Zavadil J., and Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24 (2005) 5764-5774
45. Medici D., Hay E.D., and Goodenough D.A. Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell 17 (2006) 1871-1879
46. Zavadil J., Cermak L., Soto-Nieves N., et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23 (2004) 1155-1165
47. Kaimori A., Potter J., Kaimori J., et al. TGF-beta 1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282 (2007) 22089-22101
48. Zeisberg M., Yang C., Martino M., et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282 (2007) 23337-23347
49. Zeisberg M., Shah A.A., and Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 280 (2005) 8094-8100
50. Li R., Rosendahl A., Brodin G., et al. Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol 176 (2006) 6777-6784